We provide 1 form of Pralsetinib
Pralsetinib
2097132-94-8
|
533.266
|
3.073
Pralsetinib is a RET receptor tyrosine kinase inhibitor for the treatment of metastatic RET-driven non-small cell lung cancer.
BLU-667 | pralsetinib
Pralsetinib is a RET receptor tyrosine kinase inhibitor for the treatment of metastatic RET-driven non-small cell lung cancer.
BLU-667 | pralsetinib
$147/5 mg
(EBC)
1
We provide 0 compound for Pralsetinib